Abundance of a Natural Odour in Human Cerebrospinal Fluid After Olfactory Exposure - Trial NCT06370845
Access comprehensive clinical trial information for NCT06370845 through Pure Global AI's free database. This Phase 1 trial is sponsored by University Hospital, Basel, Switzerland and is currently Not yet recruiting. The study focuses on Overweight and Obesity. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital, Basel, Switzerland
Timeline & Enrollment
Phase 1
May 01, 2024
Oct 30, 2024
Primary Outcome
Detection of a natural odour in human CSF
Summary
The goal of this clinical trial is to investigate the abundance of a natural odour in human
 cerebrospinal fluid in obese and lean participants after inhalation thereof. Participants
 will undergo blood sample collection and inhalation of either a natural odour or placebo
 through an inhaler in addition to a liquor puncture prescribed in standard of care context.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06370845
Non-Device Trial